Randomised Clinical Trial to Determine the Effect of Vagus Nerve Neurodynamics on the Neurovegetative Nerve System in People With Chronic Stress.
NCT ID: NCT06499662
Last Updated: 2024-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
62 participants
INTERVENTIONAL
2024-03-23
2024-07-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vagus Nerve Stimulation Effects on Autonomic Nervous System Activity
NCT06086236
Non-invasive Modulation of Autonomic Cardiac Nervous System
NCT04057508
Effects of Transcutaneous Vagus Nerve Stimulation in Older Adults
NCT07292623
Balance, Autonomic Response, and Sensory Modulation to Dosage of Mechanical Vagal Stimulation in Healthy Adults
NCT06541808
Understanding the Effects of Transauricular Vagus Nerve Stimulation on Neural Networks and Autonomic Nervous System
NCT05801809
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study involves 62 participants who will be randomly allocated into two groups. Group 1 will receive a protocol of guided breathing combined with neurodynamics and manual therapy, while Group 2 will follow a protocol of guided breathing with manual therapy only.
Each participant will undergo a 15-minute intervention session where HRV will be continuously monitored using Polar® H10 sensors. The intervention will include guided diaphragmatic breathing at 6 bpm to standardize the respiratory rate across participants, ensuring that HRV measurements reflect the effects of neurodynamics rather than respiratory variations.
The neurodynamics technique involves passive movements in the cervical region to enhance the functionality of the vagus nerve, potentially influencing HRV. This technique will be applied during the intervention period, with specific movements synchronized with the participants' respiratory cycle.
Prior to the intervention, baseline HRV will be recorded during a 7-minute rest period. Post-intervention HRV measurements will also be taken for 7 minutes while participants remain in a supine position. Data analysis will focus on comparing the HRV changes between the two groups, providing insights into the effectiveness of combining neurodynamics with guided breathing and manual therapy.
The study adheres to ethical guidelines and has received approval from the Medical Research Ethics Committee of Hospital Clínico San Carlos
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vagus Nerve Neurodynamics and Guided Breathing with Manual Therapy
Participants in this arm will receive a combination of vagus nerve neurodynamics and guided breathing at a rate of 6 breaths per minute (bpm), along with manual therapy. The neurodynamics intervention involves passive movements in the cervical region to enhance vagus nerve function, synchronized with the guided breathing. The manual therapy will include suboccipital inhibition techniques to complement the intervention. The total duration of the intervention will be 15 minutes.
Vagus Nerve Neurodynamics
This intervention involves passive cervical movements designed to enhance vagus nerve functionality.
Guided Breathing
This intervention consists of diaphragmatic breathing guided by a recording to maintain a rate of 6 breaths per minute.
Manual Therapy
This intervention includes suboccipital inhibition techniques applied during the session.
Guided Breathing with Manual Therapy
Participants in this arm will receive only guided breathing at a rate of 6 breaths per minute (bpm) along with manual therapy. The guided breathing will be diaphragmatic, following a recording that marks the times for inhalation and exhalation. The manual therapy will include suboccipital inhibition techniques applied during the breathing. The total duration of the intervention will be 15 minutes.
Guided Breathing
This intervention consists of diaphragmatic breathing guided by a recording to maintain a rate of 6 breaths per minute.
Manual Therapy
This intervention includes suboccipital inhibition techniques applied during the session.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vagus Nerve Neurodynamics
This intervention involves passive cervical movements designed to enhance vagus nerve functionality.
Guided Breathing
This intervention consists of diaphragmatic breathing guided by a recording to maintain a rate of 6 breaths per minute.
Manual Therapy
This intervention includes suboccipital inhibition techniques applied during the session.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-perceived chronic stress for at least six months.
* Willingness to provide informed consent and comply with the study procedures
Exclusion Criteria
* Significant neck pain or headache.
* Carotid sinus syndrome.
* Pregnancy.
* Recent cervical or cardiac surgery.
* Recent significant trauma.
* Cancer.
* Neurological disorders affecting muscle tone.
* Underlying conditions such as diabetes mellitus or arterial hypertension.
* Use of beta-blockers.
* Arrhythmias or other cardiac diseases
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Rey Juan Carlos
OTHER
Marta de la Plaza
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marta de la Plaza
Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marta de la plaza
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VNNHRV2024-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.